Prospective 2-year Data Collection of the First 10 Patients After Ankle Spacer Implantation
1 other identifier
observational
8
1 country
1
Brief Summary
Osteochondral defects (OCD) of the talus are pathologic lesions of the talar cartilage and its subchondral bone and might severely deteriorate the quality of life. For the treatment of multiple and/or large talar OCDs and in patients with failed previous surgical treatment the Ankle Spacer was developed. Six patients are included in a prospective clinical and radiological study with a follow-up of two years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2019
CompletedFirst Submitted
Initial submission to the registry
March 2, 2020
CompletedFirst Posted
Study publicly available on registry
March 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 19, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 3, 2021
CompletedSeptember 16, 2021
September 1, 2021
2 years
March 2, 2020
September 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prospective 2-year Data Collection of the First 10 Patients after Ankle Spacer Implantation
Prospective 2-year Data Collection of the First 10 Patients after Ankle Spacer Implantation
2 Years
Eligibility Criteria
The average age is 41.7 years (20 - 70 years). Patients with multiple and/or large talar osteochondral defects (OCD) and patients with failed previous surgical treatment for OCD or osteoarthritis of the talus with up to grade two (Kellgren-Lawrence-Score) osteoarthritis on the tibial site are included.
You may qualify if:
- Women and men aged 18-80 years
- Indication for implantation of the ankle spacer
You may not qualify if:
- Florid infections
- Relevant circulatory disorders on the affected leg
- Malposition of the OSG (upper ankle Joint) greater than 5 ° varus or valgus
- Fractures of the OSG or near the ankle that were less than 6 months ago
- Obesity with a BMI greater than 30 kg / m2
- Known insulin-dependent diabetes mellitus
- Known rheumatoid Arthritis
- Osteoarthritis of the OSG II ° or higher according to Kellgren / Lawrence
- Deformation of the OSG, which does not allow implantation of the ankle spacer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Orthopädische Klinik der Medizinischen Hochschule Hannover im DIAKOVERE Annastift
Hanover, Lower Saxony, 30625, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias Lerch, PD Dr.
Orthopädische Klinik der Medizinischen Hochschule Hannover im DIAKOVERE Annastift
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2020
First Posted
March 5, 2020
Study Start
January 18, 2019
Primary Completion
January 19, 2021
Study Completion
September 3, 2021
Last Updated
September 16, 2021
Record last verified: 2021-09